Metabolic Orchestration of Cell Death by AMPK-mediated Phosphorylation of RIPK1.

Tao Zhang,Daichao Xu,Elijah Trefts,Mingming Lv,Hiroyuki Inuzuka,Guobin Song,Min Liu,Jianlin Lu,Jianping Liu,Chen Chu,Min Wang,Huibing Wang,Huyan Meng,Hui Liu,Yuan Zhuang,Xingxing Xie,Fabin Dang,Dongxian Guan,Yuqin Men,Shuwen Jiang,Cong Jiang,Xiaoming Dai,Jing Liu,Zhen Wang,Peiqiang Yan,Jingchao Wang,Zhenbo Tu,Mrigya Babuta,Emily Erickson,Alissandra L. Hillis,Christian C. Dibble,John M. Asara,Gyongy Szabo,Piotr Sicinski,Ji Miao,Yu-Ru Lee,Lifeng Pan,Reuben J. Shaw,Junying Yuan,Wenyi Wei
DOI: https://doi.org/10.1126/science.abn1725
IF: 56.9
2023-01-01
Science
Abstract:Adenosine monophosphate–activated protein kinase (AMPK) activity is stimulated to promote metabolic adaptation upon energy stress. However, sustained metabolic stress may cause cell death. The mechanisms by which AMPK dictates cell death are not fully understood. We report that metabolic stress promoted receptor-interacting protein kinase 1 (RIPK1) activation mediated by TRAIL receptors, whereas AMPK inhibited RIPK1 by phosphorylation at Ser 415 to suppress energy stress–induced cell death. Inhibiting pS415-RIPK1 by Ampk deficiency or RIPK1 S415A mutation promoted RIPK1 activation. Furthermore, genetic inactivation of RIPK1 protected against ischemic injury in myeloid Ampkα1 -deficient mice. Our studies reveal that AMPK phosphorylation of RIPK1 represents a crucial metabolic checkpoint, which dictates cell fate response to metabolic stress, and highlight a previously unappreciated role for the AMPK-RIPK1 axis in integrating metabolism, cell death, and inflammation.
What problem does this paper attempt to address?